Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

2 Growth Stocks Wall Street Analysts Think Can Soar by at Least 80%


The S 500 remains near record levels as the markets have been strong this year. Finding good stocks to buy in such a hot market can be challenging. But a couple of growth stocks with lots of potential, based on their price targets from Wall Street, are Viking Therapeutics (NASDAQ: VKTX) and Riot Platforms (NASDAQ: RIOT). Here's how high they could go, according to Wall Street, and whether these are slam-dunk buys for investors.

Analysts see Viking potentially doubling in value over the course of the next 12 months; it has a consensus price target of more than $112. Analysts have generally been bullish on the pharmaceutical company, setting buy ratings for Viking recently.

That optimism stems from the hopes analysts and investors have for VK2735, a glucagon-like peptide 1 (GLP-1) treatment that has been demonstrating encouraging results in clinical trials. The potential for the drug to take market share in a $100 billion anti-obesity market has made Viking an attractive speculative investment with a lot of potential upside.

Continue reading


Source Fool.com

Viking Therapeutics Inc Stock

€46.49
-1.560%
A loss of -1.560% shows a downward development for Viking Therapeutics Inc.

Like: 0
Share

Comments